JSM 2015 Preliminary Program

Online Program Home
My Program

Legend: Washington State Convention Center = CC, Sheraton Seattle = S, Grand Hyatt = GH and The Conference Center = TCC
* = applied session       ! = JSM meeting theme

Activity Details
259 ! Mon, 8/10/2015, 2:00 PM - 3:50 PM CC-613
Clinical Trial Design II — Contributed Papers
Biopharmaceutical Section , Biometrics Section
Chair(s): Chia-Wen Ko, FDA
2:05 PM Doubly Robust Risk Estimation in the Presence of Informative Censoring Incorporating Time-Dependent Covariates — Takuya Kawahara, The University of Tokyo ; Yutaka Matsuyama, The University of Tokyo
2:20 PM Ignoring Site-Specific Treatment Effects in Multicenter Clinical Trials Increases False Positive Results — Eric Macklin, Massachusetts General Hospital/Harvard University
2:35 PM Influence of Prior on Bayesian Sample Size Calculation — Kevin Hou, Incyte Corporation ; Gongfu Zhou, Incyte Corporation ; Yufan Zhao, Incyte Corporation
2:50 PM Reference-Scaled Margin for Lot Consistency Study — Jin Xu, Merck ; G. Frank Liu, Merck
3:05 PM Multistage Adaptive Biomarker-Directed Targeted Clinical Trial Design — Zhong Gao, OBE/CBER/FDA ; Ming Tan, Georgetown University ; Anindya Roy, University of Maryland, Baltimore County
3:20 PM Assessing the Current and Potential Use of Adaptive Study Designs in Emergency Medicine Clinical Trials — Laura Flight, University of Sheffield ; Steven A. Julious, University of Sheffield ; Steve Goodacre, University of Sheffield
3:35 PM Identify Sources of Placebo Response Early to Improve the Probability of Success in Late-Stage Program — Weining Robieson, AbbVie ; Jun Zhao, AbbVie ; Deli Wang, AbbVie




For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home